SCHEMBL3176485

SCHEMBL3176485

COc1ccc(OCC(=O)O)cc1OC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.62
POLB P06746 2/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
CSNK2A2 P19784 1/20 0.55
CSNK2B P67870 1/20 0.55
CSNK2A1 P68400 1/20 0.55
PTPN7 P35236 1/20 0.54
MCL1 Q07820 1/20 0.54
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA7 P43166 1/20 0.53
CA9 Q16790 1/20 0.53
CA14 Q9ULX7 1/20 0.53
TSHR P16473 1/20 0.52
KDM4E B2RXH2 1/20 0.52
HSD17B10 Q99714 1/20 0.51
MAPT P10636 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5397033 0.95 POLB (0.64) LMNAPOLBSMN1; SMN2MEN1KMT2A
SCHEMBL25685569 0.88 POLB (0.64) LMNAPOLBSMN1; SMN2MEN1KMT2A
SCHEMBL11212890 0.86 KMT2A (0.57) LMNAPOLBMEN1KMT2ACA12
SCHEMBL10851561 0.86 RAB9A (0.57) LMNAPOLBSMN1; SMN2CA12CA1
SCHEMBL9797681 0.85 SMN1; SMN2 (0.60) LMNAPOLBSMN1; SMN2MEN1KMT2A
SCHEMBL13634529 0.85 TSHR (0.59) LMNAPOLBSMN1; SMN2MEN1KMT2A
SCHEMBL19555416 0.85 MCL1 (0.67) LMNAPOLBSMN1; SMN2PTPN7MCL1
SCHEMBL7489395 0.85 MCL1 (0.62) LMNAPOLBSMN1; SMN2PTPN7MCL1
SCHEMBL9274238 0.84 KMT2A (0.56) LMNAPOLBMEN1KMT2ACA12
SCHEMBL11212886 0.84 CA12 (0.52) LMNAPOLBSMN1; SMN2KMT2ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9181229-B2 Azole derivative TAISHO PHARMACEUTICAL CO., LTD. (JP) 2015-11-10 US disclosed
EP-2687524-B1 AZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO LTD (JP) 2015-09-30 EP disclosed
US-20140142074-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2014-05-22 US disclosed
US-20140142074-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2014-05-22 US disclosed
EP-2687524-A1 AZOLE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2014-01-22 EP disclosed
US-20130345419-A1 AZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2013-12-26 US disclosed
US-20130079313-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2013-03-28 US disclosed
US-20130079313-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2013-03-28 US disclosed
US-20100022604-A1 PROPHYLACTIC OR THERAPEUTIC AGENT FOR ALOPECIA TAISHO PHARMACEUTICAL CO., LTD. (JP) 2010-01-28 US disclosed
EP-2100588-A1 PROPHYLACTIC OR THERAPEUTIC AGENT FOR ALOPECIA Taisho Pharmaceutical Co. Ltd. (JP) 2009-09-16 EP disclosed
EP-0874805-B1 PHENYLACETAMIDE DERIVATIVES KOREA RES INST CHEM TECH (KR) 2000-09-20 EP disclosed
US-5973201-A ANALGESICS; ANTIINFLAMMATORY AGENTS KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 1999-10-26 US disclosed
EP-0340652-A2 Dye sensitized photographic imaging system EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1989-11-08 EP disclosed
US-4859572-A Dye sensitized photographic imaging system EASTMAN KODAK COMPANY (US) 1989-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022604-A1 PROPHYLACTIC OR THERAPEUTIC AGENT FOR ALOPECIA PSAP, TMSB10, TSLP LMNA 4498/4885POLB 1319/4885SMN1; SMN2 4846/4885
US-20130079313-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS PDE4A, PDE4B, PDE3A LMNA 1562/4885POLB 739/4885SMN1; SMN2 2568/4885
US-20130345419-A1 AZOLE DERIVATIVE FKBP3, FKBP2, FKBP1A LMNA 4761/4885POLB 4602/4885SMN1; SMN2 4859/4885
US-20140142074-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS PDE4A, PDE4B, PDE3A LMNA 1562/4885POLB 739/4885SMN1; SMN2 2568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.